Showing results (371-380 of 513) with videos related to

Sort By:
Pageof 52
Cancers|July 2, 2021
Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Using Integrated Clinico-Genomic Data of Endoscopic Ultrasound-Guided Fine Needle BiopsyJoo Kyung Park, Hyemin Kim, Dae-Soon Son, et al.
Cancer|June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapySehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
European Journal of Immunology|June 9, 2020
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLCJiae Koh, Youjin Kim, Kyoung Young Lee, et al.
Journal for Immunotherapy of Cancer|March 6, 2025
Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancerHyein Jeong, Jaemoon Koh, Sehui Kim, et al.
The Oncologist|February 24, 2019
A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaBhumsuk Keam, Keun-Wook Lee, Se-Hoon Lee, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapyViktor Grünwald, Pierre I Karakiewicz, Sevil E Bavbek, et al.
Journal of Korean Medical Science|February 18, 2004
The outcomes of hypertransfusion in major ABO incompatible allogeneic stem sell transplantationSe Hoon Park, Mark Hong Lee, Se Hoon Lee, et al.
Korean Journal of Radiology|August 1, 2013
True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysisYong Sub Song, Seung Hong Choi, Chul-Kee Park, et al.
Journal of Breast Cancer|January 25, 2013
Body mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean dataKyung-Hun Lee, Bhumsuk Keam, Seock-Ah Im, et al.
JTO Clinical and Research Reports|September 16, 2024
Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced <i>ALK</i>-Positive NSCLC: Five-Year Update From the Phase 3 ALESIA StudyCaicun Zhou, You Lu, Sang-We Kim, et al.
Pageof 52